Related Experiment Video

Updated: Aug 7, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Hormone replacement therapy: primary and secondary prevention

S Penckofer1, D Schwertz

  • 1Department of Medical-Surgical Nursing, School of Nursing, Loyola University Medical Center, Maywood, Illinois 60153, USA. spencko@luc.edu

The Journal of Cardiovascular Nursing
|September 13, 2003
PubMed

Insights

Understanding hormone replacement therapy (HRT) cardiovascular effects remains limited. This review synthesizes current research on HRT

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Clinical Medicine

Background:

  • The precise mechanisms of hormone replacement therapy (HRT) impacting cardiovascular health are not fully elucidated.
  • Clinical trial data to definitively clarify HRT's cardiovascular effects will not be available for several years.
  • Patients require current information on HRT risks and benefits for informed decision-making.

Purpose of the Study:

  • To review the existing research on hormone replacement therapy's role in cardiovascular disease prevention.
  • To consolidate findings from observational studies and clinical trials regarding HRT's cardiovascular impact.
  • To provide guidance for clinicians counseling patients on HRT use.

Main Methods:

  • Review of observational studies on hormone replacement therapy and cardiovascular outcomes.
  • Analysis of completed and ongoing clinical trials investigating HRT's effects.
  • Synthesis of data on the benefits and risks associated with HRT.

Main Results:

  • Current understanding of HRT's cardiovascular mechanisms remains incomplete.
  • Observational data and early clinical findings suggest complex and potentially variable cardiovascular effects.
  • Significant clinical trial results are pending, necessitating cautious interpretation of existing data.

Conclusions:

  • Practitioners need to understand the current, albeit limited, evidence on HRT's cardiovascular risks and benefits.
  • Counseling patients requires a balanced presentation of available research, acknowledging uncertainties.
  • Further research and long-term clinical trials are crucial for definitive guidance on HRT use in cardiovascular prevention.

More Related Videos

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model05:32

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model

Published on: August 11, 2023

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...